Business Description
Founded in 2014 and headquartered in Paramus, New Jersey, Polaryx Therapeutics is a clinical-stage company focused on developing treatments for rare inherited metabolic diseases, particularly those affecting children. The company is advancing several oral drug candidates alongside a gene therapy program, all targeting conditions where the body's cells struggle to break down certain biological materials. Its work aims to address the underlying causes of these diseases rather than simply managing symptoms.
